FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal carcinoma. (1st March 2017)

• Record Type: Journal Article
• Authors: Wang, F.F.; Zhang, X.J.; Yan, Y.R.; Zhu, X.H.; Yu, J.; Ding, Y.; Hu, J.L.; Zhou, W.J.; Zeng, Z.C.; Liao, W.T.; Ding, Y.Q.; Liang, L.
• Is Part Of: Cancer letters. Volume 388(2017)
• Page Start: 85
• Page End: 95
• Publication Date: 2017-03-01
• Subjects: FBX8 -- miR-223 -- mTOR -- Ubiquitin degradation -- Colorectal carcinoma; Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.canlet.2016.11.031
• Languages: English
• ISSNs: 0304-3835

Abstract

Abstract: F-box proteins are critical components of the SKP1-CUL1-F-box (SCF) E3 ubiquitin ligases and involved in the ubiquitin-dependent proteolytic pathway. Dysregulation of F-box protein-mediated proteolysis often leads to human malignancies. F-box only protein 8 (FBX8), a novel component of F-box proteins, is down-regulated in several tumors and closely correlates with tumor progression. However, little is known about its function, regulatory mechanisms and substrates in the progression of colorectal carcinoma (CRC). Combining microRNA (miRNA) assay, functional characterization, mechanistic studies with clinical validation, we identify FBX8 as a CRC metastasis suppressor downstream of miR-223, a metastasis promoting miRNA that is transcriptionally regulated by Myocyte enhancer factor (MEF2A). mTOR is a substrate of FBX8 for ubiquitin-mediated degradation and is required for FBX8 induced cell proliferation and invasion in CRC cells. FBX8 is down-regulated in human CRC tissues and correlates with MEF2A, miR-223 and mTOR expression levels. Notably, low FBX8 expression status in CRC tissues was a significant prognostic factor for poor overall survival of patients. These findings illustrate FBX8 as a metastasis suppressor that functions through mTOR signaling pathway and has significant prognostic power. Highlights: FBX8, a downstream target of microRNA-223, is a novel tumor suppressor gene in colorectal cancer. FBX8 plays tumor suppressing role in colorectal cancer through ubiquitination mediated degradation of mTOR. The Sec7 domain of FBX8 directly binds mTOR through the major conserved CPD site.